The influence of anti-osteoporotic drugs on fracture risk, bone mineral density, and side effect in senile osteoporosis treatment: a network meta-analysis of randomized controlled trials

Zongyi Zhou; Qiwei Yang; Lu Liu; Weiying Guo; Feng Xu; Yadong Liu; Xin Li; Yanhua Wu; Nan Zhou; Hanxin Yao; Chengluan Xuan; Yuanyi Wang

doi:10.1016/j.heliyon.2026.e45032

Q1 2026

The influence of anti-osteoporotic drugs on fracture risk, bone mineral density, and side effect in senile osteoporosis treatment: a network meta-analysis of randomized controlled trials

Zongyi Zhou · Qiwei Yang · Lu Liu · Weiying Guo · Feng Xu · Yadong Liu · Xin Li · Yanhua Wu · Nan Zhou · Hanxin Yao · Chengluan Xuan · Yuanyi Wang

10.1016/j.heliyon.2026.e45032 393 Views 0 Citations

Citations

393

Views

Abstract not available for this publication.

Cite this Article (APA)

Zongyi, Z., Qiwei, Y., Lu, L., Weiying, G., Feng, X., Yadong, L., Xin, L., Yanhua, W., Nan, Z., Hanxin, Y., Chengluan, X., Yuanyi, W. (2026). The influence of anti-osteoporotic drugs on fracture risk, bone mineral density, and side effect in senile osteoporosis treatment: a network meta-analysis of randomized controlled trials. Heliyon. https://doi.org/10.1016/j.heliyon.2026.e45032